一、「台灣血栓暨止血學會109年度年會」
將於民國109年8 月15日(週六)
假張榮發基金會國際會議中心801廳(台北市中正區中山南路11號8樓舉行
因為疫情影響，盡量採取梅花座的安排，
有實體演講也有直播視訊演講(可與外賓溝通討論)，敬邀會員踴躍參加。
二、本會第四屆第一次會員大會謹訂於民國109年8月15日(週六)15:00~16:20 於同場地(801廳)召開 敬請會員準時出席及投票。
會費繳納通知書已陸續於7月中至7月底以電子郵件方式 寄給各別會員，敬請特別留意。
不得單獨領取他人(委託人)之「理監事選舉票兌換券」。
教育積分：申請中。
台灣血栓暨止血學會 109 年度年會
2020 TSTH Annual Meeting
時間：109年08月15日 09:00 -17:00
地點:張榮發基金會國際會議中心801廳
大會主席：彭慶添理事長
|
時間 |
題目 |
講者 |
|
|
|
|
09:00-12:00 |
註冊 |
||||
|
09:20-09:30 |
開幕致詞 |
彭慶添理事長 |
|
||
|
會員演講一 Moderator: 林東燦教授/陳宇欽教授 |
|||||
|
09:30-09:45 |
Personalized treatment with PK-guided tools (Takeda) |
侯人尹醫師/台北馬偕 |
|
||
|
09:45-10:00 |
ITI regimen of Nuwiq-real world experience sharing (AKSO） |
錢新南醫師/童綜合 |
|
||
|
10:00-10:15 |
Severe hemophilia A with high titer inhibitor and acute myocardial infarction:a case report with literature review |
王建得醫師/中榮 |
|
||
|
10:15-10:30 |
Influence of Genetic Polymorphisms of Biological Mediators on the Phenotypic Heterogeneity in Hemophilic Arthropathy |
陳宇欽醫師/三總 |
|
||
|
10:30-10:50 |
Coffee Break |
||||
|
會員演講二 Moderator: 王建得醫師/邱世欣教授 |
|||||
|
10:50-11:05 |
Characterization of hereditary factor XI deficiency in Taiwanese patients: Identification of three novel mutations and two common mutations |
林炫聿醫師/彰基 |
|
||
|
11:05-11:20 |
Cerebral venous thrombosis in Young Adolescents: OCPs related Protein S deficiency |
翁德甫醫師/中山 |
|
||
|
專題演講一 Moderator: 彭慶添教授 |
|||||
|
11:20-12:00 |
Acquired Thrombotic Thrombocytopenic Purpura (aTTP) |
沈銘鏡教授/彰基 |
|
||
|
Lunch symposium 12::00-13:45(非台灣血栓暨止血學會之會員，午餐請自理) |
Moderator |
||||
|
12:00-12:35 |
Lunch symposium I (Novonordisk) |
楊永立醫師 |
彭慶添教授 |
|
|
|
12:35-13:10 |
Lunch symposium II (Novartis) |
王建得醫師 |
陳宇欽教授 |
|
|
|
13:10-13:45 |
Lunch symposiumIII(Bayer) |
林敬業醫師 |
沈銘鏡教授 |
|
|
|
專題演講二 (Sanofi) Moderator: 沈銘鏡教授 |
|||||
|
What makes Hemophilia B different? |
Dr. Guy Young |
|
|||
|
14:25-15:00 |
Coffee Break |
||||
|
會員大會 |
|||||
|
15:00-16:20 |
年度會員大會（學會理監事投開票） |
||||
|
Satellite Symposium (中外) |
Moderator |
||||
|
16:20-16:55 |
What can we expect for Emicizumab in the future- current status of clinical studies and case sharing |
林敬業醫師 |
沈銘鏡教授 |
|
|
台灣血栓暨止血學會 109 年度年會
2020 TSTH Annual Meeting
時間：109年08月16日 08:00-12:00
地點：台北萬豪酒店
大會主席：彭慶添理事長
|
時間 |
題目 |
講者 |
|
08:00 -08:10 |
Opening |
沈銘鏡教授 |
|
專題演講三 Moderator 沈銘鏡教授 |
||
|
08:10-09:00 |
Patient considerations in an era of evolving approaches to hemophilia care |
Dr. Glenn Pierce/ (Vice President of WFH) |
|
Moderator Dr. Glenn Pierce |
||
|
09:00-09:40 |
Case Sharing: Outcome of Liver transplantation for hemophilia |
林敬業醫師/彰基 |
|
09:40-09:50 |
Panel Discussion |
|
|
09:50-09:55 |
Coffee Break |
|
|
會員演講四 Moderator徐會祺教授/林敬業醫師 |
||
|
09:55-10:10 |
Correlating clinical and radiological assessment of joints in haemophilia: results of a cross sectional study |
翁德甫醫師/中山 |
|
10:10-10:25 |
The Outcome of Standard Half-life Coagulation Factor VIII Prophylaxis Treatment for Severe Hemophilia A Patients – A Longitudinal study |
邱世欣醫師/高醫 |
|
10:25-10:40 |
Transfusion-transmitted infection and comorbidities in patients with severe haemophilia: a longitudinal birth cohort analysis |
王建得醫師/中榮 |
|
10:40-10:55 |
Switching from standard half-life to extended half-life products: clinical observations and pharmacokinetics in patients with severe hemophilia A |
林佩瑾醫師/高醫 |
|
10:55-11:05 |
Coffee Break |
|
|
11:05-11:20 |
Acquired FXIII inhibitor: patient characteristics and treatment outcome, a case series in Taiwan |
周聖傑醫師/台大 |
|
11:20-11:35 |
Clinical Experience of rFVIII-Fc Used in Patients with Hemophilia A in Taiwan: Regimen Adjustment, Annual Joint Bleeding Rates, Annual Factor Costs, Correlation Factors of Pharmacokinetics, and Effects on Joint Health |
張家堯醫師/北醫 |
|
11:35-11:50 |
Recurrent amaurosis fugax or transient visual loss experienced in a patient of familial antithrombin III deficiency |
范聖暐醫師/彰基 |
|
11:50-12:00 |
閉幕致詞 |
沈銘鏡教授 |
